Post sponsored by

Source: United Kingdom – Executive Government & Departments

SARS-CoV-2 vaccines have the potential to end the global pandemic of COVID-19; however, many challenges remain.

Data Evaluation and Learning for Viral Epidemics (DELVE), a multi-disciplinary group convened by the Royal Society, is releasing its latest report on the key challenges in developing, evaluating, manufacturing and distributing a vaccine for COVID-19, the impact of these challenges and future strategies to mitigate their effects.


Speakers included:

Prof Charles Bangham, Chair of Immunology; Co-Director, Institute of Infection, Imperial College London

Dr Fiona Culley, National Heart and Lung Institute, Imperial College London

Prof Nilay Shah, Head of Department of Chemical Engineering, Imperial College London

MIL OSI United Kingdom